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Results: A total of 129 women ware included: 85 DMD and 44 BMD carriers. 
Thalr mean age was 37 ± 10 years. Mean LVend diastolic diameter (LVED) 
was 50 -I- 5 ram, mean shortening fraction (SF) was 37 d: 7%, and mean 
Et0oint septal separation (EPSS) was 5 ~ 2 mm. None had more than mild 
mitral, aort~ or tricuspid rogu~itatlen. Fourteen DMD and 4 BMD Carders 
had LV abnormalities. LV dilatation (LVED > 57 ram) was observed in 8 
DMD, reduced SF (< 27%) in I BMD and 3 DMD, increased EPSS (> 8 mm) 
in 1 BMD and 6 DMD, and 4 DMD had regional wag motion abnom~itias. 
Diastolic dysfunction (E/A ratio < 1) was noted in 2 BMD and 2 DMD. Six 
DMD carriers were considered to have dilated cardiomyopothy. 
Conclusion: LV dysfunctino is more frequently seen in DMD as compared 
to BMD Carriem. Nthough most carders appear to have normal LV function, 
manifest cardiomyopathy isseen in 7% of DMD caniem. 
Lymphocytic _1~. cardtltis In Childhood: Incidence 
and Outcame wollowing uual  Therapy 
Immunosuppmselon 
Sabine Kieinert, Palriota Kelly, James Wilkinson, Chung-Wo Chow, 
Robert Weinfraub. Royal Children's Hospital, Melbourne, Australia 
The true incidence of ~ i t i s  in children with acute d~ted ca~liomyopa- 
thy (DCM) is unkswn and reported outcome with supportive therapy alone 
is variable. Although animal models suggest that immune mechanisms play 
an important role in the pathoEP-rL~, i-~ of .myocarditis, the efficacy of immune- 
suppression in humans has not been established. 
Early endomyocardial b~psy was performed 26 consecutive children with 
acute DCM. Group i patients (n = 8; 31%) with "definite" myocarditis (lym- 
phocytic infiltrate + myocardial necrosis) were treated with cydaspodne and 
prednisoione, with follow-up biopsies prior to withdrawal of therapy. Group 
It patients (n = 3; 11%) with "berdedina" myocarditis (lymphec~ic infiltrate 
alone) and Group 01 (remaining patients; n = 15; 58%) received conven- 
tional medical therapy. Echocardlographic Z scores were derived from 300 
age-matched control subjects. Them were no non-invasive features ~at 
distinguished Group I patients from the other groups. 
Group I Group lit P value 
Early LVEOd Z score S.O :1:0.6 4.1-1- 0.5 NS 
Early FS Z score -5.2 :E 0.3 -5.9 :E 0.3 NS 
Late LVEDd Z score 0.8 =E0.3" 3.0:E0.8 <0.05 
Late FS Z score -0.9:E0.4 ~ -2.69=0.7 0.06 
Echo ~p/  8/8 5/15 < 0.05 
Death 0/8 4/15 NS 
*P < 0.01 by compar;son ~ ear;y Z so,re 
Two Group I patients had late echecerdiogrephic and biopsy worsening 
which responded to reinstits~on of immunosuppressicn. 
Lymphocytic myocordftis is frequent in children with acute DCM. Dual 
therapy immunosuppression isassociated with a faveurabic outcome. These 
preliminary data point to the need for a specific controlled trial of dual therapy 
immunosuppreSSicn i poedistdc patients. 
] '9 -~ Altered Myocardial Phenotype Following 
Mechanloal Support in Humans Wlth Advanced 
Cardiomyopathy 
Gregory Aitemose, Vedim Gdtsus, Bruce Goldman, Valluvan Jeevana~,  
Kenneth Marguties. Temple University School of Medicine, Philadelphia, PA 
Left vantdcotar assist devices (LVAD) provide lifesaving circulatory support 
to patients 8waiting orthotopio heart transplantation. To date, the extent o 
which sustained mechanical unloading alters the phenotype of pathologic my- 
ocardial hype~rophy in dilated Cardiomyopathy is unknown. Therefore, we 
examined LV size, myocyts msrpheme W and atrial natduretic peptide (ANP) 
immunoreactlvtty in eight patients with advanced ilated celdiomyopathy be- 
fore and after LVAD support. The mean duration of CHF was 18 ~ 5 months, 
and LVAD support averaged 42 4- 4 days prior to head transplantation. 
Pra-LVAD Post-LVAD 
Mean PA pressure (mmHg) 41 :t: 2 23 ~: 3" 
PA wedge pressure (mmHg) 29 :E 3 17 :t: 3* 
Cardiac Index (1/mitring) 1.9 .-4:0,2 2,8 :E 0.2* 
LV shod axis diameter (cm) 7.8 9= 0.9 5.5 ± 0.5* 
LV Mass (grams) 339 :E 60 205 :E 2P 
Myocyle diameter (~ml 28.1~- 0.9 21.7:E 0.6" 
All values mean 9= SEM, "p < 0,05 vS. Pre.LVAD 
As shown above, hemodynamio support and unloading with the LVAD re. 
ducad echocardiographlcally determined LV dilation and LV mass. Minimum 
myocyte diameter at the level of the nucleus also decreased foflOwing LVAD 
support. Overall left vectricuisr ANP immunopositivity decreased from 48% 
at LVAD placement to 12% at transplantation (p < 0.05), and there was a 
close correlation (r = 0.82, p < 0,001 ) between left ventricular mass and ANP 
immunopositivity before and after LVAD support, These studies demonstrate 
remarkable t.v plasticity even In the presence of advanced ¢ardiomyopa- 
thy, Reductions in ventdcular ANP Irnmunostalnlng also suggest that LVAD 
support induces a unique change in the phenotype of pathologic cardiac 
hypeerophy. 
~ Idlol~lhl¢ Familial Dilated Card iomyopsthy:  
Idenffiying Early Disease In Asymptonlatlc 
Relatives 
M. Kammn Baig, Jonathan H. Goldman, Philip J. Keeling, Aman S. Coonar, 
Mitautoshi Yamada, Allda LR  Cafodo, William J. McKenna, St Georges 
Hospital, London, UK 
Background ~ Familial disease is present In > 25% of patimP, s with dilated 
cerdiomyopathy (DCM). The ~hility to identify esymptomatio relatives with 
early disease is a malor goat in understanding pathogenesls and improving 
management. 
Method--We assessed 321 asymptomatio relatives (mean age 35 =1:15, 
t93 male) of 70 DCM patients 0NHO criteria). 
Resu l ts -  59 (20%) had LV enlargement (LVE = > 11L>~ predicted 
LVEDd), 21(7%) had depressed fractional shortening (dfs = FS < 25%) 
and the remainder had normal dimensions and contractility (NOR). Diss- 
tolio dysfunction (AbN E/A ratio) was present in 40 (68%) LVE retatives and 
60(41%) NOR. LVE's had lOwer FS (33:1: 5% vs 35 :J: 6=, p < 0.05), and 
longer total QRS (98 =1:12 ms vs 94:1:10 ms, p = 0.05), than those with 
normal aches. A greater proportion of LVE had abnormal VO2 Max (< 80% 
predicted) compared to NOR (6.10% vs 7.4%; p < 0,05). Dta's had larger 
LVDd% predicted (112 -4-13 vs 102 ~ 7, p < 0,001), and lower RMS VOltage 
(34 :J: 18 my vs 58 :E 40 ray, p = 0.05) than NOFL The mean F-/A ratio of 
relatives (n = 100) was tower than predicted E/A ratio, (1.55 + 0.83 vs 1.75 ± 
0.44, p = 0,03) and LVE had lower E/A ratio than NOR (1.29 :E 0.72 vs 1,60 
:E 0.71, p = 0.04). Over 27.5 :E 14.3 months follow*up, 9 relatives developed 
DCM and one (m3h mild palpitations) died suddenly. 
Conclusions --Asymptomatic relatives commonly have echocardiographte 
abnormalities; the metabolic and SA-ECG abnormalitiee also obsozved sug- 
gest these two echo abnormalities may represent early DCM. 
~ Chronic Adenos ine  Rec~.lPt_Or B lockade Prevents 
Attenuation o f  Adrenergl© e(seponsivenesez in Left 
Ventrtculor Hypertrophy 
Eugene S. Chang, Thao E. Meyer, James G. Dobson Jr, Richard A. Fenten, 
Gerard P, Audgemma, William H. Gaasch. Univemity Massachusetts 
Medical Center,, Worcester, MA 
Left ventricular hypertrophy (LVH) is associated with reduced adranergic re- 
sponsiveness (AR). Acutely, adenosine (ADO) levels increase in respoilse 
to increased myocardmt work and exhibit an anttadrenergic action. To deter- 
mine whether chronic blockade of the ADO receptor or ADO uptake would 
alter AR in LVH, rats with LVH, induced by supmrenal aortic banding (B), 
and sham operated rats (S) were each subdivided into 3 treatment groups, 
with the last dose given 24 hours before sasflflce: theophylline (ADO mcepter 
blocker; 20 mg/kg tp bid, groups BT, ST), dlpyfldemole, (ADO uptake blocker; 
5 mg/kg ip bid, groups BD, SD), or 0.9% NaCI (2 mt/kg iD bid, groups BN, 
SN). At 9 weeks, hearts were perfusad with physiological saline solution at 
a pressure predetermined by the carotid blood pressure. AR to isopretorenol 
was assessed at 4 doses. Data are shown as mean :E SEM; MBP = Mean 
BP (mmHg); LVwt ,= dry LV weight (mg/g body weight); ~dPIdt = maximal 
change in +dP/dt (mmHg/s); ECso = log M concentration at 50% of maximal 
response; 
BT(n21) BD(n19) BN(n16) ST(n16) 
MBP 134 125 137 94 
:~51 ±91 ±61" 9=5 
LVwt 0.57 0.58 0.61 0,42 
0,021 + 0.02 t ± 0,02 t 9= 0.01 
LzdP/dt 3587 2832 2999 4461 
~: 161 :t:286 t :E 2121 9=270 
ECS0 -8.14 -8.05 -8,14 -8.21 
-I-0.02 ±0.07" -I-0,03 ±0.03 
1'9 < 0.0001; •p < 0.05 vs. respective sham controls. 
SD(n16) (SN(nl?) 
92 106 
=E4 ::E4 
0.41 0.41 
:E0.01 -I-0,01 
4020 4149 
± 369 ± 258 
-8.23 -8.23 
=1:0.02 4- 0.02 
Conclusions: Data confirm reduced AR in LVH. Chronic blockade of ADO 
uptake reduces the AR, while chronic recaptor blockade prevents attanua~n 
of AR in LVH. 
